Navigation Links
Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
Date:4/22/2008

gin the delivery in fall 2008 of 20,000 doses of ABthrax to the Strategic National Stockpile under a contract entered into with the U.S. Government in June 2006. Other HGS drugs in clinical development include two TRAIL receptor antibodies for the treatment of cancer. In addition, HGS1029, a small-molecule antagonist of IAP (inhibitor of apoptosis) proteins, is expected to enter Phase 1 clinical trials for the treatment of cancer in early 2008. HGS also has substantial financial rights to certain products in the GlaxoSmithKline clinical development pipeline.

For information about HGS, please visit the Company's web site at http://www.hgsi.com . Health professionals or patients interested in clinical trials of HGS products may inquire via email to clinical_trials@hgsi.com, or by calling (301) 610-5790, extension 3550.

HGS, Human Genome Sciences, ABthrax, Albuferon and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and costs associated with facilities, intense competition, the un
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
2. Data Show SuperGens MP-470 is Safe in Humans
3. Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
4. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
5. Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
6. ExonHits EHT 0202 Counters Scopolamines Detrimental Effects on Cognition in Humans
7. Valor Medical Announces First Human Implant of Neucrylate AN(TM) for Treatment of Cerebral Aneurysm
8. Synbiotics Corporation Announces Human Submission for FluDetect(R)
9. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
10. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
11. N30 Pharma Announces Successful Initiation of Human Studies With N30-201
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... , April 20, 2015  Sigma-Aldrich Corporation ... Corporate Responsibility (CR) Magazine,s list of the 100 ... on outstanding corporate responsibility performance.  Sigma-Aldrich ranked fifth, ... appearance on the list. "We are ... corporate responsibility efforts and we are extremely pleased ...
(Date:4/20/2015)... The preclinical contract research organization Absorption Systems ... safety testing of medical devices, announces that its Chief Scientist, ... " Drug Transporters in ADME: From the Bench to the ... title of Dr. Hidalgo,s talk is "Modern Tools for the ... Tools of the Future." The workshop, organized jointly ...
(Date:4/20/2015)...  Ameritox,s Ingenuity Health, a leading provider of monitoring ... at the National Council of Behavioral Health annual conference ... nearly 25 percent of the samples collected from patients ... prescribed antipsychotic medication. ... Medication nonadherence ...
Breaking Medicine Technology:Sigma-Aldrich Named to CR Magazine's 100 Best Corporate Citizens List 2Absorption Systems Chief Scientist Ismael Hidalgo to Present at International Workshop on Drug Transporters 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 3
... FOREST, Ill., April 11, 2011 PharMEDium Healthcare Corporation ... of Anesthesiologists (ASA), as a part of a new ... practice management companies. David N. Jonas, PharMEDium ... ASA,s efforts to advance the anesthesiology field through leadership, ...
... In response to Thursday,s Medicare Payment Advisory ... substantially higher levels of advanced diagnostic imaging services ... approval before being able to provide those services, ... instead look to existing clinical decision support tools ...
Cached Medicine Technology:PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA) 2Healthcare Providers, Technology Experts Call for Use of Existing Decision Support Tools to Promote Diagnostic Imaging Appropriate Use 2Healthcare Providers, Technology Experts Call for Use of Existing Decision Support Tools to Promote Diagnostic Imaging Appropriate Use 3
(Date:4/21/2015)... 2015 The Northeast Football Clinic (NEFC) ... Academy prep school in Byfield, MA. Applications are being ... boys entering grades 6-12. , The outstanding professional, college, ... fall coaching. , Offensive and defensive linemen ... these the most unsung positions on the field, the ...
(Date:4/21/2015)... Dr. Zain Kadri, a Beverly Hills plastic ... takes a close look at the rise of plastic surgery ... on both Dr. Kadri’s website and RedOrbit , is ... Age of the Selfie.” According to Dr. Kadri, who offers ... variety of A-list patients, the trend of taking selfies has ...
(Date:4/21/2015)... Sunnyvale, CA (PRWEB) April 21, 2015 ... research solutions for biopharmaceutical development, today announced that the ... at the University of Ottawa has acquired a Freeslate ... and Screening Pressure Reactor (SPR) to accelerate ... the High-Throughput Experimentation Facility where they will be available ...
(Date:4/21/2015)... Spring and summer are popular seasons to ... for the holidays or simply taking vacations. Deciding what ... can be a difficult choice. Pet-friendly accommodations are gaining ... becoming a more common option. Royal Flush Havanese ... pet-friendly accommodations a positive experience. , 1.) Firstly, it ...
(Date:4/21/2015)... This program provides physical therapists, ... occupational therapist assistants, teachers, and other school based ... children across the autism spectrum succeed in the ... Inc. , Used throughout the United ... yoga curriculum addresses learning and behavior issues across ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:Beverly Hills Plastic Surgery Expert Dr. Zain Kadri Releases Thought-Provoking New Infographic 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 2Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 3Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 4Health News:ABC News Interviews Anne Buckley-Reen, Education Resources Inc. Faculty Member, on Yoga Therapy in the Classroom 2
... To Stay Happy and Healthy This WinterSAN JOSE, Calif., ... avoiding the "winter blues" is to set small goals, ... and exercising, for a well-rounded approach to life. This ... Day of the Year," January 26, 2009, designated by ...
... Strong Health and Economic Benefits of OTC Heartburn ... Consumer Healthcare Products Association (CHPA) and The Nielsen ... over-the-counter (OTC) heartburn medications and estimates that OTC ... each in office visits and medication costs annually. ...
... and print media; Mike Ditka, Frank Gifford, Michael Irvin, Tony Dorsett, ... Dickerson, Deacon Jones, Andre Reed, Tony Dorsett, Mercury Morris and many ... ... January 26, 2009 -- The Gridiron Greats Assistance Fund ...
... Inc. announces leading stem cell specialist Dr Nabil Dib, MD as ... President of the International Society for Cardiovascular Translational Research (ISCTR) and ... ... San Diego, CA (PRWEB) January 26, 2009 -- Stemedica Cell ...
... DNA solves another mystery when 57 year old Fred George discovered he ... fun and sometimes more seriously - accused his wife of having had ... rest of the family. , ... Pembroke, MA (PRWEB) January 26, 2009 ...
... injuries accounted for just 8 percent of all ... were relatively common in predominately male sports such ... (18 percent) and football (12 percent). Moreover, boys ... in soccer and baseball/softball. , ...
Cached Medicine News:Health News:Natural Solutions for the Most Depressing Day of the Year 2Health News:Natural Solutions for the Most Depressing Day of the Year 3Health News:Natural Solutions for the Most Depressing Day of the Year 4Health News:Natural Solutions for the Most Depressing Day of the Year 5Health News:CHPA, Nielsen: OTC Heartburn Therapy Saves Nearly $800 Million Annually, Vast Majority of OTC Heartburn Consumers Satisfied 2Health News:CHPA, Nielsen: OTC Heartburn Therapy Saves Nearly $800 Million Annually, Vast Majority of OTC Heartburn Consumers Satisfied 3Health News:100 NFL Legends Coming Together in Tampa During Super Bowl Week to Raise Awareness and Funds for Retired Players in Crisis 2Health News:100 NFL Legends Coming Together in Tampa During Super Bowl Week to Raise Awareness and Funds for Retired Players in Crisis 3Health News:100 NFL Legends Coming Together in Tampa During Super Bowl Week to Raise Awareness and Funds for Retired Players in Crisis 4Health News:Dr Nabil Dib Takes on Special Advisor Role to the Stemedica Board of Directors 2Health News:DNA Solves Switched at Birth Mystery ... After 57 Years 2Health News:DNA Solves Switched at Birth Mystery ... After 57 Years 3Health News:Shoulder injuries in US high school athletes occur more often in boys 2
... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek® ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
... Endoscopic CycloPhotocoagulation (ECP) is a surgical ... endoscopy and visualized laser application. The ciliary ... by the surgeon, from the anterior or ... time. The target tissues are easily and ...
... a surgical approach to glaucoma management that ... The ciliary body (which produces aqueous humour) ... anterior or posterior segment, through the endoscope ... easily and accurately identified utilizing endoscopy. This ...
... (ECP) is a surgical approach to glaucoma ... laser application. The ciliary body (which produces ... from the anterior or posterior segment, through ... tissues are easily and accurately identified utilizing ...
Medicine Products: